tradingkey.logo

Upexi Inc

UPXI
2.040USD
-0.220-9.73%
收盘 12/15, 16:00美东报价延迟15分钟
120.14M总市值
0.07市盈率 TTM

Upexi Inc

2.040
-0.220-9.73%

关于 Upexi Inc 公司

Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

Upexi Inc简介

公司代码UPXI
公司名称Upexi Inc
上市日期Jun 24, 2021
CEOMarshall (Allan)
员工数量59
证券类型Ordinary Share
年结日Jun 24
公司地址3030 Rocky Point Drive
城市TAMPA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33607
电话17013535425
网址https://upexi.com/
公司代码UPXI
上市日期Jun 24, 2021
CEOMarshall (Allan)

Upexi Inc公司高管

名称
名称/职务
职务
持股
持股变动
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.51M
+899.43%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
685.37K
+17.08%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
589.14K
+68.74%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
名称
名称/职务
职务
持股
持股变动
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.51M
+899.43%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
685.37K
+17.08%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
589.14K
+68.74%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q1
业务USD
名称
营收
占比
Internally manufactured
9.26M
62.48%
Contract manufactured
2.79M
18.80%
Purchased as finished goods
2.78M
18.73%
地区USD
名称
营收
占比
United States of America
14.57M
98.25%
Other
259.57K
1.75%
业务
地区
业务USD
名称
营收
占比
Internally manufactured
9.26M
62.48%
Contract manufactured
2.79M
18.80%
Purchased as finished goods
2.78M
18.73%

股东统计

更新时间: 11月22日 周六
更新时间: 11月22日 周六
持股股东
股东类型
持股股东
持股股东
占比
Polar Asset Management Partners Inc.
7.91%
Samara Special Opportunities
7.16%
GSR Growth Investments LP
4.25%
Marshall (Allan)
2.39%
Alyeska Investment Group, L.P.
1.98%
其他
76.30%
持股股东
持股股东
占比
Polar Asset Management Partners Inc.
7.91%
Samara Special Opportunities
7.16%
GSR Growth Investments LP
4.25%
Marshall (Allan)
2.39%
Alyeska Investment Group, L.P.
1.98%
其他
76.30%
股东类型
持股股东
占比
Hedge Fund
11.97%
Corporation
11.41%
Investment Advisor
8.44%
Individual Investor
6.08%
Research Firm
2.38%
Investment Advisor/Hedge Fund
1.36%
Bank and Trust
0.45%
Venture Capital
0.05%
其他
57.86%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
60
18.50M
31.42%
+11.94M
2025Q2
46
10.18M
21.50%
+7.63M
2025Q1
42
311.78K
28.56%
-35.31K
2024Q4
42
307.62K
23.29%
-32.82K
2024Q3
40
303.51K
29.16%
-55.91K
2024Q2
40
319.39K
30.68%
-45.58K
2024Q1
42
328.34K
32.32%
-46.59K
2023Q4
42
319.26K
31.43%
-34.26K
2023Q3
40
369.15K
37.28%
-46.01K
2023Q2
44
368.80K
38.85%
-28.58K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Samara Special Opportunities
4.53M
7.69%
+4.53M
--
Aug 29, 2025
GSR Growth Investments LP
2.31M
3.92%
-1.00
-0.00%
Jun 30, 2025
Marshall (Allan)
1.51M
2.57%
+1.36M
+899.43%
Jul 16, 2025
Rudick (Brian Benjamin)
838.60K
1.42%
+400.00K
+91.20%
Jul 16, 2025
MMCAP Asset Management
12.94M
21.98%
+12.94M
--
Jul 16, 2025
The Vanguard Group, Inc.
500.84K
0.85%
+500.84K
--
Jun 30, 2025
Salkind (Gene)
585.37K
0.99%
+220.24K
+60.32%
Jul 16, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
公告日期
类型
比率
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1

常见问题

Upexi Inc的前五大股东是谁?

Upexi Inc 的前五大股东如下:
Samara Special Opportunities持有股份:4.53M,占总股份比例:7.69%。
GSR Growth Investments LP持有股份:2.31M,占总股份比例:3.92%。
Marshall (Allan)持有股份:1.51M,占总股份比例:2.57%。
Rudick (Brian Benjamin)持有股份:838.60K,占总股份比例:1.42%。
MMCAP Asset Management持有股份:12.94M,占总股份比例:21.98%。

Upexi Inc的前三大股东类型是什么?

Upexi Inc 的前三大股东类型分别是:
Polar Asset Management Partners Inc.
Samara Special Opportunities
GSR Growth Investments LP

有多少机构持有Upexi Inc(UPXI)的股份?

截至2025Q3,共有60家机构持有Upexi Inc的股份,合计持有的股份价值约为18.50M,占公司总股份的31.42%。与2025Q2相比,机构持股有所增加,增幅为9.93%。

哪个业务部门对Upexi Inc的收入贡献最大?

在FY2025,Internally manufactured业务部门对Upexi Inc的收入贡献最大,创收9.26M,占总收入的62.48%。
KeyAI